Please join us for a robust discussion reviewing 2022 insurance trends and marketplace challenges and what we expect to see in 2023. Three industry veterans will discuss what occurred in […]
The biosimilars for the blockbuster drug Humira® will hit the market in 2023. Join our team as we discuss the complexities surrounding biosimilars, how they may influence the pharmacy landscape […]
Increasingly, employer groups have expressed interest in establishing on-site health centers and other supplemental benefit programs as options for their employees. Employers cite the need to help control costs under […]
Under Federal law, group health plans are responsible for various new reporting and disclosure requirements that aim to improve transparency within the healthcare industry. This webinar will review the key […]
Please join us for a robust discussion addressing important issues and trends involving Social Engineering and what can be done to minimize your risk. Three industry veterans will address and […]
Most employers offer their employees healthcare options that include account-based plans—Health FSAs, HRAs or HSAs. According to the International Foundation of Employee Benefits (IFEBP) 2022 Employee Benefits Survey, nearly 70% […]
Please join us for a robust discussion addressing important issues and trends in the Workers' Compensation marketplace. Three industry veterans will address and discuss Return to Work Programs and their […]
The federal government plans to end much of the relief provided for under the original declaration of the COVID-19 National Emergency made on March 13, 2020. On May 4, 2020, […]
Please join us for a robust discussion addressing important issues and trends in the Fiduciary Liability marketplace. Three industry veterans will address and discuss current trends in the claims and […]
Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help […]
Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help […]
With a more diverse workforce, employers are receiving additional questions from employees regarding how Medicare enrollment interacts with, or otherwise affects, coverage under an employer-sponsored health benefit plan. In this session, we will explore the interaction between group health plans and Medicare and answer many of the questions employers/plan sponsors are asking about Medicare coverage, […]
